Characterization of Autoantibodies in Pemphigus Using Antigen-Specific Enzyme-Linked Immunosorbent Assays with Baculovirus-Expressed Recombinant Desmogleins

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 2010-2017

  Ishii, Ken ^a   Amagai, Masayuki ^a   Hall, Russell P ^b   Hashimoto, Takashi ^a   Takayanagi, Atsushi ^a   Gamou, Shinobu ^a   Shimizu, Nobuyoshi ^a   Nishikawa, Takeji ^a  

^a KEIO UNIVERSITY   (Japan)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOSKELETON PROTEIN; DESMOGLEIN; DESMOGLEIN 1; DESMOPLAKIN; DSG1 PROTEIN, HUMAN; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN;

ARTICLE; BACULOVIRUS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOLOGY; PEMPHIGUS;

AUTOANTIBODIES; BACULOVIRIDAE; CYTOSKELETAL PROTEINS; DESMOGLEIN 1; DESMOGLEINS; DESMOPLAKINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; PEMPHIGUS; RECOMBINANT PROTEINS;

EID: 0031571268     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Stanley, J. R. 1993. Pemphigus. In Dermatology in General Medicine. T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg, and K. F. Austen, eds. MacGraw-Hill, New York, p. 606-614.
2. Anhalt, G. J., R. S. Labib, J. J. Voorhees, T. F. Beals, and L. A. Diaz. 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306:1189.
3. Hashimoto, K., K. M. Shafran, P. S. Webber, G. S. Lazarus, and K. H. Singer. 1983. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J. Exp. Med. 157:259.
4. Stanley, J. R. 1993. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv. Immunol. 53:291.
5. Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869.
6. Amagai, M. 1996. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv. Dermatol. 11:319.
7. Amagai, M., T. Hashimoto, N. Shimizu, and T. Nishikawa. 1994. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:59.
8. Amagai, M., T. Hashimoto, K. J. Green, N. Shimizu, and T. Nishikawa. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104:895.
9. Amagai, M., S. Karpati, R. Prussick, V. Klaus-Kovtun, and J. R. Stanley. 1992. Autoamibodies against the ammo-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J. Clin. Invest. 90:919.
10. Dmochowski, M., T. Hashimoto, M. Amagai, J. Kudoh, N. Shimizu, P. J. Koch, W. W. Franke, and T. Nishikawa. 1994. The extracellular aminoterminal domain of bovine desmoglein I (Dsg1) is recognized only by certain pemphigus foliaceus sera, whereas its intracellular domain is recognized by both pemphigus vulgaris and pemphigus foliaceus sera. J. Invest. Dermatol. 103:173.
11. Kowalczyk, A. P., J. E. Anderson, J. E. Borgwardt, T. Hashimoto, J. R. Stanley, and K. J. Green. 1995. Pemphigus sera recognize conformationally sensitive epitopes in the ammo-terminal region of desmoglein-1 (Dsg1). J. Invest. Dermatol. 105:147.
12. Amagai, M., K. Ishii, T. Hashimoto, S. Gamou, N. Shimizu, and T. Nishikawa. 1995. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J. Invest. Dermatol. 105:243.
13. Nilles, L. A., D. Parry, E. E. Powers, B. D. Angst, R. M. Wagner, and K. J. Green. 1991. Structural analysis and expression of human desmoglein: a cadherin-like component of the desmosome. J. Cell Sci. 99:809.
14. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
15. Amagai, M., K. Ishii, A. Takayanagi, T. Nishikawa, and N. Shimizu. 1996. Transport to endoplasmic reticulum by signal peptide, but not proteolytic processing, is required for formation of Conformational epitopes of pemphigus vulgaris antigen (Dsg3). J. Invest. Dermatol. 107:539.
16. Hashimoto, T., M. M. Ogawa, A. Konohana, and T. Nishikawa. 1990. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J. Invest. Dermatol. 94:327.
17. Eyre, R. W., and J. R. Stanley. 1988. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J. Clin. Invest. 81:807.
18. Emery, D. J., L. A. Diaz, J. A. Fairley, A. Lopez, A. F. Taylor, and G. J. Giudice. 1995. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J. Invest. Dermatol. 104:323.
19. Rock, B., R. S. Labib, and L. A. Diaz. 1990. Monovalent Fab′ immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal BALB/c mice. J. Clin. Invest. 85:296.
20. Katz, S. I., K. M. Halprin, and T. M. Inderbitzin. 1969. The use of human skin for the detection of anti-epithelial autoantibodies: a diagnostic and prognostic test. J. Invest. Dermatol. 53:390.
21. O'Loughlin, S., G. C. Goldman, and T. T. Provost. 1978. Fate of pemphigus antibody following successful therapy. Arch. Dermatol. 114:1769.
22. Beutner, E. H., T. P. Chorzelski, and S. Jablonska. 1985. Immunofluorescence tests: clinical significance of sera and skin in bullous diseases. Int. J. Dermatol. 24:405.
23. Acosta, E., J. J. H. Gilkes, and L. Ivanyi. 1985. Relationship between the serum autoantibody titers and the clinical activity of pemphigus vulgaris. Oral Surg. Oral Med. Oral Pathol. 60:611.
24. Judd, K. P., and H. Mescon. 1979. Comparison of different epithelial substrates useful for indirect immunofluorescence testing of sera from patients with active pemphigus. J. Invest. Dermatol. 72:314.
25. Amagai, M., P. J. Koch, T. Nishikawa, and J. R. Stanley. 1996. Pemphigus vulgaris antigen (Desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106:351.